Goldman Sachs’s Lipocine LPCN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-25,952
| Closed | -$21K | – | 5586 |
|
|
2022
Q2 | $21K | Sell |
25,952
-62,663
| -71% | -$50.7K | ﹤0.01% | 5410 |
|
|
2022
Q1 | $121K | Buy |
88,615
+74,428
| +525% | +$102K | ﹤0.01% | 5251 |
|
|
2021
Q4 | $14K | Buy |
+14,187
| New | +$14K | ﹤0.01% | 5481 |
|
|
2021
Q1 | – | Sell |
-57,824
| Closed | -$79K | – | 5311 |
|
|
2020
Q4 | $79K | Buy |
+57,824
| New | +$79K | ﹤0.01% | 4506 |
|
|
2020
Q3 | – | Sell |
-20,851
| Closed | -$26K | – | 4507 |
|
|
2020
Q2 | $26K | Buy |
+20,851
| New | +$26K | ﹤0.01% | 4296 |
|
|
2017
Q3 | – | Sell |
-74,541
| Closed | -$300K | – | 4339 |
|
|
2017
Q2 | $300K | Buy |
+74,541
| New | +$300K | ﹤0.01% | 3796 |
|
|
2016
Q2 | – | Sell |
-32,130
| Closed | -$326K | – | 4583 |
|
|
2016
Q1 | $326K | Buy |
32,130
+20,441
| +175% | +$207K | ﹤0.01% | 3489 |
|
|
2015
Q4 | $151K | Sell |
11,689
-7,702
| -40% | -$99.5K | ﹤0.01% | 3846 |
|
|
2015
Q3 | $229K | Sell |
19,391
-1,918
| -9% | -$22.7K | ﹤0.01% | 3784 |
|
|
2015
Q2 | $183K | Sell |
21,309
-716
| -3% | -$6.15K | ﹤0.01% | 4053 |
|
|
2015
Q1 | $152K | Sell |
22,025
-584
| -3% | -$4.03K | ﹤0.01% | 4012 |
|
|
2014
Q4 | $119K | Sell |
22,609
-3,827
| -14% | -$20.1K | ﹤0.01% | 4201 |
|
|
2014
Q3 | $162K | Buy |
+26,436
| New | +$162K | ﹤0.01% | 4062 |
|